When will Chemist Warehouse shares be trading on the ASX?

A $9 billion monster is being created but when can you invest?

| More on:
Female pharmacist smiles with a digital tablet.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Earlier today, Sigma Healthcare Ltd (ASX: SIG) shares returned from their trading halt with an almighty bang.

Investors were scrambling to buy shares in response to its proposed merger with Chemist Warehouse.

If it completes successfully, this merger will create a ~$9 billion industry behemoth with earnings before interest and tax of $495 million.

Unsurprisingly, investors may now be wondering when they will be able to buy Chemist Warehouse shares. Well, let's take a look and find out.

When will Chemist Warehouse shares be trading on the ASX?

Firstly, you don't technically have to wait for Chemist Warehouse shares to arrive on the ASX boards if you want them in your portfolio.

That's because if the merger with Sigma Healthcare goes ahead, the Amcal owner's shares will become the shares of the merged entity, which is currently known as MergeCo.

Therefore, anyone owning Sigma shares today will own a slice of MergeCo if shareholders and regulators approve the transaction.

But when might that happen?

While the Sigma share price reaction today appears to indicate that the market is both happy with the merger plan and believes it will complete successfully, there's still a bit of work to be done before then.

Sigma's management notes that the proposed merger is expected to complete in the second half of calendar year 2024 if all goes to plan. But it could be worth the wait according to them.

Chemist Warehouse's chair, Jack Gance, believes the merger is the start of another big chapter. He said:

The combination of CWG's retailing and marketing capabilities and Sigma's state-of-the-art distribution infrastructure and logistics capabilities presents a unique opportunity for both CWG and Sigma shareholders. We look forward to building the next chapter of CWG's success for the benefit of our customers, staff, franchisees and shareholders.

This view was echoed by Sigma's chair, Michael Sammells. He adds:

The Proposed Merger is a step-change event for Sigma. With Sigma having had a commercial relationship with CWG and its founders spanning more than 40 years, we are excited by the efficiencies, synergies and growth opportunities that we anticipate being unlocked through the merger of the two complementary businesses. The combined group will have extensive capabilities and expertise to benefit franchisees and customers, including through more brand choice, products and services and expanded marketing capabilities.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Male doctor in a lab coat working at laptop looking serious.
Healthcare Shares

This bombshell for ASX healthcare shares could hit 6 million Australians

This could have a large impact.

Read more »

Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
Healthcare Shares

2 ASX healthcare shares having a stellar run today

The ASX healthcare sector is down today but these two stocks are bucking the trend.

Read more »

A company manager presents the ASX company earnings report to shareholders at an AGM.
Healthcare Shares

Why this $13 billion ASX 200 healthcare stock is surging today

A change in sentiment for the healthcare player.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

This ASX 200 stock hit a 52-week low and a top broker thinks it can rebound

Patient investors may see this stock make a pleasing recovery.

Read more »

A couple smile as they look at a pregnancy test.
Healthcare Shares

Why this sold-off ASX healthcare share could be an exciting dividend buy

This could be a healthy stock for dividends.

Read more »

a smiling woman sits at her computer at home with a coffee alongside her, as if pleased with her investments.
Healthcare Shares

Is CSL the best ASX 100 share to buy now?

Bell Potter has good things to say about this blue chip star.

Read more »

Scientists in a laboratory look at a computer screen with anticipation on their faces representing a potential change in the performance of ASX biotech shares in FY23
Healthcare Shares

Down 10% in a month, are CSL shares feeling the sting of a potential disruption?

Brokers are still bullish.

Read more »

One girl leapfrogs over her friend's back.
Healthcare Shares

Doubled in a year! Does this booming ASX share have another 24% upside?

Let's take a look.

Read more »